Professor Stefan Pöhlmann
German Primate Center
Professor, Life Sciences
Germany
My co-authors include
Dr David Ross Darley
Professor Jonathan Luke Heeney
Dr Mikhail N Matrosovich
Find me at
My Publications
Virosomes interfere with Ebola virus control by the immune system
Cell Reports
February 2019
We show that the Ebola virus glycoprotein can be incorporated into non-infectious particles, termed virosomes. Virosomes can serve as antibody decoys and modulate macrophage function. The Interfero...
Inhibition of lectin-dependent enhancement of Ebola virus entry into cells
Journal of the American Chemical Society
August 2017
The cellular lectins DC-SIGN and DC-SIGNR bind to glycans present on Ebola virus and can augment viral entry into cells. This study shows that quantum dots (QD) displaying a dense array of glycans ...
The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor...
Journal of Virology
March 2013
Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin
Journal of Virology
January 2009
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus recept...
Proceedings of the National Academy of Sciences
May 2005
DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein ...
Journal of Virology
November 2004
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
Journal of Virology
April 2003
Diversity of receptors binding HIV on dendritic cell subsets
Nature Immunology
September 2002
DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian...
Proceedings of the National Academy of Sciences
February 2001
SARS-CoV-2 uses ACE2 and TMPRSS2 for infection of lung cells
Cell
April 2020
Viruses interact with host cell factors for attachment and entry into target cells. The spike (S) protein of coronaviruses facilitates host cell entry and which host cell factors are exploited by t...
Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Mult...
Angewandte Chemie International Edition
March 2016
Protease inhibitors targeting coronavirus and filovirus entry
Antiviral Research
April 2015
Furin cleavage of SARS-CoV-2 spike is required for infection of lung cells
Molecular Cell
May 2020
The S1/S2 cleavage site of the SARS-CoV-2 spike protein contains several arginine residues and is not found in closely related coronaviruses. Here, we show that this site is cleaved by the cellular...
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Cameli...
Cell
May 2020
Chloroquine does not inhibit SARS-CoV-2
Nature
July 2020
Chloroquine is a drug used to treat Malaria. Chloroquine was also found to block SARS-CoV-2 infection of the kidney cell line Vero, which is frequently used to study virus infections, and has thus...
Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19
Pharmaceuticals
January 2023
TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
Viruses
January 2023
Primate Simplexviruses Differ in Tropism for Macaque Cells
Microorganisms
December 2022
Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19
November 2022
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties...
International Journal of Molecular Sciences
November 2022
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
Viruses
November 2022
Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppressio...
Microbiology Spectrum
October 2022
Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment
Cell Research
September 2022
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nC...
Nature Communications
August 2022
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing...
Frontiers in Immunology
July 2022
Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to...
Viruses
July 2022
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture
Communications Biology
July 2022
Mutagenic Analysis of the HIV Restriction Factor Shiftless
Viruses
June 2022
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by ...
mBio
June 2022
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, St...
Journal of Medicinal Chemistry
June 2022
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
The Lancet Infectious Diseases
June 2022
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant ...
Cellular and Molecular Immunology
May 2022
Understanding Omicron: Transmissibility, immune evasion and antiviral intervention
Clinical and Translational Medicine
May 2022
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralizati...
Cell Host & Microbe
May 2022
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies...
Cell Reports
May 2022
Investigations on SARS-CoV-2 Susceptibility of Domestic and Wild Animals Using Primary ...
Viruses
April 2022
Omicron: Master of immune evasion maintains robust ACE2 binding
Signal Transduction and Targeted Therapy
April 2022
Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein
PLoS ONE
March 2022
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclo...
European Journal of Immunology
March 2022
Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of hi...
European Journal of Immunology
March 2022
Alternatives to animal models and their application in the discovery of species suscept...
Veterinary Pathology
February 2022
The Omicron variant is highly resistant against antibody-mediated neutralization: Impli...
Cell
February 2022
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
Journal of Virology
January 2022
MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humo...
Cellular and Molecular Immunology
January 2022
No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
Cellular and Molecular Immunology
January 2022
A Recombinant System and Reporter Viruses for Papiine Alphaherpesvirus 2
Viruses
January 2022
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates p...
Cellular and Molecular Life Sciences
January 2022
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutra...
EBioMedicine
January 2022
Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for...
Frontiers in Immunology
December 2021
Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1
Cell Research
December 2021
Erythrocytes increase endogenous sphingosine 1-phosphate levels as an adaptive response...
Clinical Science
December 2021
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in pr...
Kidney International
December 2021
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosa...
Nature Communications
November 2021
Spike residue 403 affects binding of coronavirus spikes to human ACE2
Nature Communications
November 2021
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-indu...
Cellular and Molecular Immunology
October 2021
Evidence that two instead of one defective interfering RNA in influenza A virus-derived...
Scientific Reports
October 2021
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry ...
Proceedings of the National Academy of Sciences
October 2021
Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance
Cellular and Molecular Immunology
October 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies i...
Cell Reports
October 2021
The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection
International Journal of Molecular Sciences
September 2021
A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease...
European Journal of Immunology
September 2021
Functional comparison of MERS-coronavirus lineages reveals increased replicative fitnes...
Nature Communications
September 2021
SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
The Lancet
September 2021
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162...
Cellular and Molecular Immunology
August 2021
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 ...
Nature Reports Stem Cells
July 2021
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral v...
PLoS Medicine
July 2021
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced b...
Cell Reports
July 2021
How SARS-CoV-2 makes the cut
Nature Microbiology
June 2021
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronav...
Clinical Infectious Diseases
June 2021
Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-...
Frontiers in Medicine
May 2021
Therapeutic Application of alpha-1-antitrypsin in COVID-19
American Journal of Respiratory and Critical Care Medicine
May 2021
Cell culture-based production and in vivo characterization of purely clonal defective i...
BMC Biology
May 2021
The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temper...
PLoS Pathogens
April 2021
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
Cell Reports
April 2021
The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infection
iScience
April 2021
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Cell
April 2021
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
Nature Communications
March 2021
Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing S...
STAR Protocols
March 2021
Mutation D614G increases SARS-CoV-2 transmission
Signal Transduction and Targeted Therapy
March 2021
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its m...
EBioMedicine
March 2021
Dalbavancin: novel candidate for COVID-19 treatment
Cell Research
January 2021
Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without inter...
Proceedings of the National Academy of Sciences
January 2021
Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with ca...
Chemical Science
January 2021
Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epitheli...
Journal of Biological Chemistry
January 2021
Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inh...
Chemical Science
January 2021
The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temper...
November 2020
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 co...
Cellular and Molecular Immunology
November 2020
Corrigendum: Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Pr...
Angewandte Chemie International Edition
November 2020
Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Obser...
Critical Care Explorations
November 2020
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Ep...
Cell Reports Medicine
November 2020
Sphingosine prevents binding of SARS–CoV-2 spike to its cellular receptor ACE2
Journal of Biological Chemistry
November 2020
Glycan-Gold Nanoparticles as Multifunctional Probes for Multivalent Lectin–Carbohydrate...
Journal of the American Chemical Society
September 2020
LY6E impairs coronavirus fusion and confers immune control of viral disease
Nature Microbiology
July 2020
Probing Multivalent Lectin-Carbohydrate Binding via Multifunctional Glycan-Gold Nanopar...
June 2020
Probing Multivalent Lectin-Carbohydrate Binding via Multifunctional Glycan-Gold Nanopar...
June 2020
H2 influenza A virus is not pathogenic in Tmprss2 knock-out mice
Virology Journal
April 2020
Nafamostat inhibits SARS-CoV-2
Antimicrobial Agents and Chemotherapy
April 2020
SARS-CoV-2 uses ACE2 and TMPRSS2 for infection of lung cells
January 2020
Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respirato...
Emerging Microbes & Infections
January 2020
A Fosmid-Based System for the Generation of Recombinant Cercopithecine Alphaherpesvirus...
Viruses
November 2019
Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaques
PLoS ONE
November 2019
Analysis of Resistance of Ebola Virus Glycoprotein-Driven Entry Against MDL28170, An In...
Pathogens
October 2019
Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influen...
Journal of Virology
October 2019
Spike proteins of novel MERS-coronavirus isolates from North- and West-African dromedar...
Virology
September 2019
Evidence for influenza B virus hemagglutinin adaptation to the human host: high cleavab...
August 2019
Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay
International Journal of Molecular Sciences
August 2019
Kaposi sarcoma in a guereza monkey
Emerging Infectious Diseases
August 2019
Novel Virus Related to Kaposi’s Sarcoma–Associated Herpesvirus from Colobus Monkey
Emerging Infectious Diseases
August 2019
Evidence that Calu-3 cells are largely resistant to Ebola virus entry
Virology
June 2019
Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesis
Journal of General Virology
May 2019
IFITM s mediate viral evasion in acute and chronic hepatitis C virus infection
Hepatology
May 2019
Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-M...
Cell Reports
May 2019
SPP and SKI-1 inhibitor block Ebola virus entry
PLoS ONE
April 2019
Modulation of HIV-1 Gag/Gag-Pol frameshifting by tRNA abundance
Nucleic Acids Research
April 2019
Detection of antibodies against viruses in a macaque colony using a chip-based approach
Primate Biology
March 2019
The cell Line SH-SY5Y is resistant to infection by Ebola virus and other filoviruses
Viruses
March 2019
A safe system for production of defective interfering particles
PLoS ONE
March 2019
Focal epithelial hyperplasia and papillomavirus infection in a bonobo
Pathogens
January 2019
Development and use of Lentiviral Vectors Pseudotyped with Influenza B Haemagglutinins:...
December 2018
Tetherin efficiently inhibits Nipah virus but not Ebola virus spread in fruit bat cells
Journal of Virology
November 2018
MERS-coronavirus spike protein: Importance of protease cleavage sites for viral entry
Scientific Reports
November 2018
A MERS-coronavirus variant that is partially resistant against neutralizing antibodies
Journal of Virology
November 2018
The cellular protease TMPRSS11A can convert influenza virus into an infectious form
Journal of Biological Chemistry
July 2018
Cell Entry of Influenza A Viruses: Sweet Talk between HA and Ca V 1.2
Cell Host & Microbe
June 2018
A GXXXA motif in the Ebola virus glycoprotein is required for tetherin antagonism
Journal of Virology
April 2018
Attachment/Binding
January 2018
VSV-G antagonizes tetherin in transfected cells
PLoS ONE
December 2017
Identification of sites in SARS-S required cleavage and activation by TMPRSS2
PLoS ONE
June 2017
TMPRSS2 of non-human primates activates influenza viruses
PLoS ONE
May 2017
Herpes B virus replication and viral lesions in the liver of a cynomolgus macaque which...
Journal of Medical Primatology
April 2017
pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenz...
Journal of Virology
March 2017
Rhesus macaque IFITM3 gene polymorphisms and SIV infection
PLoS ONE
March 2017
A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulate...
Journal of Virology
February 2017
Detection systems for antibody responses against herpes B virus
Primate Biology
February 2017
Evidence that Processing of the Severe Fever with Thrombocytopenia Syndrome Virus Gn/Gc...
PLoS ONE
November 2016
Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Si...
Journal of Virology
November 2016
The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Bin...
Journal of Virology
October 2016
The Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and Release
Viruses
July 2016
The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-De...
PLoS ONE
March 2016
Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Mult...
Angewandte Chemie
March 2016
The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat...
PLoS ONE
February 2016
The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by ...
Journal of Virology
February 2016
TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells
PLoS ONE
September 2015
Exclusive Decoration of Simian Immunodeficiency Virus Env with High-Mannose Type N-Glyc...
Journal of Virology
September 2015
Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin a...
Journal of Virology
June 2015
Interferon-Induced Transmembrane Protein–Mediated Inhibition of Host Cell Entry of Ebol...
The Journal of Infectious Diseases
June 2015
Analysis of Ebola Virus Entry Into Macrophages
The Journal of Infectious Diseases
April 2015
Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zai...
The Journal of Infectious Diseases
April 2015
IFITM Proteins Inhibit Entry Driven by the MERS-Coronavirus Spike Protein: Evidence f...
Viruses
September 2014
DESC1 and MSPL Activate Influenza A Viruses and Emerging Coronaviruses for Host Cell Entry
Journal of Virology
August 2014
Inhibition of Proprotein Convertases Abrogates Processing of the Middle Eastern Respira...
The Journal of Infectious Diseases
July 2014
Bitter-sweet symphony: glycan–lectin interactions in virus biology
FEMS Microbiology Reviews
July 2014
Influenza A Virus Encoding Secreted Gaussia Luciferase as Useful Tool to Analyze Viral ...
PLoS ONE
May 2014
Analysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism
Viruses
April 2014
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus c...
Journal of Antimicrobial Chemotherapy
April 2014
Induced and spontaneous heart rate turbulence in mice: influence of coupling interval
EP Europace
March 2014
Toll-Like Receptor 3 Signalling Up-Regulates Expression of the HIV Co-Receptor G-Protei...
PLoS ONE
February 2014
Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice
PLoS Pathogens
December 2013
Lack of MERS Coronavirus Neutralizing Antibodies in Humans, Eastern Province, Saudi Arabia
Emerging Infectious Diseases
December 2013
Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cu...
Antiviral Research
December 2013
TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments ...
Journal of Virology
November 2013
Platelet activation suppresses HIV-1 infection of T cells
Retrovirology
May 2013
TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry ...
Journal of Virology
March 2013
Severe Fever with Thrombocytopenia Virus Glycoproteins Are Targeted by Neutralizing Ant...
Journal of Virology
February 2013
Cellular Entry of Retroviruses
January 2013
Attachment/Binding
January 2013
Host Cell Factors in Filovirus Entry: Novel Players, New Insights
Viruses
November 2012
The role of the alternative coreceptor GPR15 in SIV tropism for human cells
Virology
November 2012
How Ebola Virus Counters the Interferon System
Zoonoses and Public Health
September 2012
Influenza A Virus Does Not Encode a Tetherin Antagonist with Vpu-Like Activity and Indu...
PLoS ONE
August 2012
Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Mu...
PLoS ONE
April 2012
Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient ent...
Virology
March 2012
CD4- and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells
Virology
February 2012
Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells
The Journal of Infectious Diseases
November 2011
The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract th...
The Journal of Infectious Diseases
November 2011
The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan...
PLoS Pathogens
October 2011
Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Prot...
Journal of Virology
October 2011
DC-SIGN: Access Portal for Sweet Viral Killers
Cell Host & Microbe
July 2011
Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell...
Virology
May 2011
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike...
Journal of Virology
February 2011
Mouse LSECtin as a model for a human Ebola virus receptor
Glycobiology
January 2011
The multiple facets of HIV attachment to dendritic cell lectins
Cellular Microbiology
September 2010
TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 ...
Journal of Virology
July 2010
A Single Asparagine-Linked Glycosylation Site of the Severe Acute Respiratory Syndrome ...
Journal of Virology
June 2010
Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is req...
Retrovirology
May 2010
Novel insights into proteolytic cleavage of influenza virus hemagglutinin
Reviews in Medical Virology
May 2010
Peptide-Based Inhibitors of the HIV Envelope Protein and Other Class I Viral Fusion Pro...
Current Pharmaceutical Design
March 2010
Calcium-modulating cyclophilin ligand does not restrict retrovirus release
Nature Reports Stem Cells
February 2010
Lectin-like interactions in virus–cell recognition
January 2010
Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory S...
Journal of Virology
October 2009
Cellular Entry of the SARS Coronavirus: Implications for Transmission, Pathogenicity an...
October 2009
Type II transmembrane serine proteases in cancer and viral infections
Trends in Molecular Medicine
July 2009
Carbohydrates on HIV: mediators of immune evasion and targets for antiviral intervention
Future HIV Therapy
May 2008
Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: Differential pH depend...
Virology
March 2008
Analysis of the Interaction of Ebola Virus Glycoprotein with DC‐SIGN (Dendritic Cell–Sp...
The Journal of Infectious Diseases
November 2007
A Novel Mechanism for LSECtin Binding to Ebola Virus Surface Glycoprotein through Trunc...
Journal of Biological Chemistry
November 2007
Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin
Virology
November 2007
Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion...
Cell
April 2007
A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or co...
Virology
April 2007
The C-type Lectin Receptors CLEC-2 and Dectin-1, but Not DC-SIGN, Signal via a Novel YX...
Journal of Biological Chemistry
March 2007
Attachment of human immunodeficiency virus to cells and its inhibition
January 2007
DC-SIGN and CLEC-2 Mediate Human Immunodeficiency Virus Type 1 Capture by Platelets
Journal of Virology
September 2006
Modulation of virion incorporation of Ebolavirus glycoprotein: Effects on attachment, c...
Virology
September 2006
Highly Conserved Regions within the Spike Proteins of Human Coronaviruses 229E and NL63...
Journal of Virology
September 2006
The Signal Peptide of the Ebolavirus Glycoprotein Influences Interaction with the Cellu...
Journal of Virology
July 2006
Cellular Entry of HIV: Evaluation of Therapeutic Targets
Current Pharmaceutical Design
June 2006
Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens
Virology
April 2006
Functional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGN
International Immunology
March 2006
Evidence that multiple defects in murine DC-SIGN inhibit a functional interaction with ...
Virology
February 2006
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CL...
Blood
January 2006
Interaction Between the Spike Protein of Human Coronavirus NL63 and its Cellular Recept...
January 2006
Attachment Factor and Receptor Engagement of Sars Coronavirus and Human Coronavirus NL63
January 2006
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus
Virology
September 2005
Cellular entry of the SARS coronavirus
Trends in Microbiology
October 2004
Differential regulation of human immunodeficiency virus type 2 and simian immunodeficie...
Virology
July 2004
Prospects of HIV-1 entry inhibitors as novel therapeutics
Reviews in Medical Virology
July 2004
Susceptibility to SARS coronavirus S protein-driven infection correlates with expressio...
Biochemical and Biophysical Research Communications
July 2004
S Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Mediates Entry in...
Journal of Virology
June 2004
Amino Acid 324 in the Simian Immunodeficiency Virus SIVmac V3 Loop Can Confer CD4 Indep...
Journal of Virology
April 2004
Mutations in the C3 region of human and simian immunodeficiency virus envelope have dif...
Virology
October 2003
Differential N-Linked Glycosylation of Human Immunodeficiency Virus and Ebola Virus Env...
Journal of Virology
January 2003
DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and ...
Virology
January 2003
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, ...
Proceedings of the National Academy of Sciences
November 2002
Quantitative Expression and Virus Transmission Analysis of DC-SIGN on Monocyte-Derived ...
Journal of Virology
September 2002
The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therap...
Expert Opinion on Therapeutic Targets
August 2002
Hemofiltrate CC Chemokine 1[9-74] Causes Effective Internalization of CCR5 and Is a Pot...
Antimicrobial Agents and Chemotherapy
April 2002
CD4 Independence of Simian Immunodeficiency Virus Envs Is Associated with Macrophage Tr...
Journal of Virology
March 2002
Evaluation of Current Approaches to Inhibit HIV Entry
Current Drug Targets - Infectious Disorders
March 2002
Expression of DC-SIGN by Dendritic Cells of Intestinal and Genital Mucosae in Humans an...
Journal of Virology
February 2002
DC-SIGN and DC-SIGNR: helping hands for HIV
Trends in Immunology
December 2001
Functional and Antigenic Characterization of Human, Rhesus Macaque, Pigtailed Macaque, ...
Journal of Virology
November 2001
DC-SIGN Interactions with Human Immunodeficiency Virus: Virus Binding and Transfer Are ...
Journal of Virology
November 2001
Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV
The Journal of Pathology
October 2001
The Role of DC-SIGN and DC-SIGNR in HIV and SIV Attachment, Infection, and Transmission
Virology
July 2001
Basic Amino Acid Residues in the V3 Loop of Simian Immunodeficiency Virus Envelope Alte...
Virology
June 2001
DC-SIGN Interactions with Human Immunodeficiency Virus Type 1 and 2 and Simian Immunode...
Journal of Virology
May 2001
Natural Proteolytic Processing of Hemofiltrate Cc Chemokine 1 Generates a Potent Cc Che...
The Journal of Experimental Medicine
November 2000
Simian Immunodeficiency Virus Utilizes Human and Sooty Mangabey but Not Rhesus Macaque ...
Journal of Virology
June 2000
Co‐receptor Usage of BOB/GPR15 in Addition to CCR5 Has No Significant Effect on Replica...
The Journal of Infectious Diseases
November 1999